wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
BLOOD-2013-07-512137
BLOOD-2013-07-512137
http://dx.doi.org/10.1182/BLOOD-2013-07-512137
A phase 1 study evaluating the safety and tolerability of otlertuzumab, an anti-CD37 mono-specific ADAPTIR therapeutic protein in chronic lymphocytic leukemia
P356
Q37609420-8B8F8037-EFEA-4031-A44D-4B4CA579152E
P356
BLOOD-2013-07-512137
http://dx.doi.org/10.1182/BLOOD-2013-07-512137